Cargando…
SARS-CoV-2 seroprevalence in the urban population of Qatar: An analysis of antibody testing on a sample of 112,941 individuals
The study objective was to the assess level of detectable severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies in the urban population of Qatar. Antibody testing was performed on residual blood specimens for 112,941 individuals (∼10% of Qatar's urban population) attending for...
Autores principales: | Coyle, Peter V., Chemaitelly, Hiam, Ben Hadj Kacem, Mohamed Ali, Abdulla Al Molawi, Naema Hassan, El Kahlout, Reham Awni, Gilliani, Imtiaz, Younes, Nourah, Al Anssari, Ghada Ali A.A., Al Kanaani, Zaina, Al Khal, Abdullatif, Al Kuwari, Einas, Butt, Adeel A., Jeremijenko, Andrew, Kaleeckal, Anvar Hassan, Latif, Ali Nizar, Shaik, Riyazuddin Mohammad, Abdul Rahim, Hanan F., Nasrallah, Gheyath K., Yassine, Hadi M., Al Kuwari, Mohamed Ghaith, Al Romaihi, Hamad Eid, Al-Thani, Mohamed H., Bertollini, Roberto, Abu-Raddad, Laith J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8142077/ https://www.ncbi.nlm.nih.gov/pubmed/34056566 http://dx.doi.org/10.1016/j.isci.2021.102646 |
Ejemplares similares
-
Assessing the performance of a serological point-of-care test in measuring detectable antibodies against SARS-CoV-2
por: Coyle, Peter V., et al.
Publicado: (2022) -
COVID-19 risk score as a public health tool to guide targeted testing: A demonstration study in Qatar
por: Abu-Raddad, Laith J., et al.
Publicado: (2022) -
Mathematical modeling of the SARS-CoV-2 epidemic in Qatar and its impact on the national response to COVID-19
por: Ayoub, Houssein H, et al.
Publicado: (2021) -
SARS-CoV-2 infection hospitalization, severity, criticality, and fatality rates in Qatar
por: Seedat, Shaheen, et al.
Publicado: (2021) -
Herd Immunity against Severe Acute Respiratory Syndrome Coronavirus 2 Infection in 10 Communities, Qatar
por: Jeremijenko, Andrew, et al.
Publicado: (2021)